Pancreatic Disorders & Therapy
Open Access

2^nd Intenational Conference on Pancreatic Disorders & Treatment

September 13-14, 2017 Dallas, USA

Keynote

• Developing therapy-responsive prognostic biomarkers, and conquering undruggable oncogenic k-ras-driven pancreatic cancer by attacking its major k-ras vulnerability and the k-ras signaling gatekeeper - the siah proteolysi

  Amy H Tang

  PDF HTML

• Human iPS cells are an alternative source of pancreatic beta cells

  Nicholas Zavazava

  PDF HTML